A leading endocrinologist with the Food and Drug Administration recommended pursuing approval for puberty blockers for youth with gender dysphoria despite acknowledging that they raised the risk of depression and suicidality, according to internal emails. Shannon Sullivan, the clinical team leader at the FDA’s Division of General Endocrinology, recommended to her supervisor in January 2022 … Continue reading FDA official behind closed doors said puberty blockers are dangerous for transgender youth